Literature DB >> 6709816

Haemoccult compliance rates and reasons for non-compliance.

V Box, S Nichols, R C Lallemand, P Pearson, P A Vakil.   

Abstract

Mesh：

Year:  1984        PMID： 6709816     DOI： 10.1016/s0033-3506(84)80055-4

Source DB:  PubMed          Journal:  Public Health        ISSN： 0033-3506            Impact factor:   2.427


× No keyword cloud information.
  8 in total

1.  Is there a preference for different ways of performing faecal occult blood tests?

Authors:  J D Kettner; C Whatrup; J E Verne; K Young; C B Williams; J M Northover
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

2.  Assessing endoscopic colorectal screening adherence in an emergency department population.

Authors:  Jennifer Christie; Denise Nassisi; Ilene Wilets; Katherine N DuHamel; Gary Winkel; Rhadjena Hilliard; Lina Jandorf
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

Review 3.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Acceptability of opportunistic screening for occult gastrointestinal blood loss.

Authors:  F D Hobbs; R C Cherry; J W Fielding; L Pike; R Holder
Journal:  BMJ       Date:  1992-02-22

5.  Understanding the barriers and facilitators of colorectal cancer screening among low income immigrant hispanics.

Authors:  Lina Jandorf; Jennie Ellison; Cristina Villagra; Gary Winkel; Alejandro Varela; Zeida Quintero-Canetti; Anabella Castillo; Linda Thélémaque; Sheba King; Katherine Duhamel
Journal:  J Immigr Minor Health       Date:  2010-08

6.  Screening for colorectal cancer.

Authors:  J Austoker
Journal:  BMJ       Date:  1994-08-06

7.  Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing.

Authors:  J E Verne; R Aubrey; S B Love; I C Talbot; J M Northover
Journal:  BMJ       Date:  1998-07-18

8.  Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072].

Authors:  Paolo Giorgi Rossi; Antonio Federici; Francesco Bartolozzi; Sara Farchi; Piero Borgia; Gabriella Guasticchi
Journal:  BMC Public Health       Date:  2005-12-22       Impact factor: 3.295
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.